
"While I'm totally for having safe and efficacious drugs on the market, we've got to make sure that the pendulum doesn't swing to the other side and we start delaying the approval for new drugs because we've become strongly averse."
In this interview, Ajit Shetty talks about escalating R&D costs in the pharmaceutical industry, the rising cost of prescription drugs, attempts to introduce uniform pricing across the world, intellectual property research and the need for the industry to educate consumers on the role of pharmaceuticals in the public health care system.
Ajit Shetty interview on the pharma industry (.mov) [23:22]
To hear more from Ajit Shetty, go to the Reunion 2006 faculty/alumni panel on International Business Leadership.